India Pesticides Reappoints Dheeraj Kumar Jain as CEO for 5 Years
India Pesticides Limited approved unaudited financial results for Q3 FY26. The Board re-appointed Mr. Dheeraj Kumar Jain as CEO for a five-year term from Jan 23, 2026, to Jan 22, 2031. Mr. Jain has over 50 years of experience and has been with the company for over 30 years.
The re-appointment of the CEO for a long term provides stability and continuity in leadership, which can positively influence investor confidence. The approval of financial results is also a key event, but without specific figures, the impact is assessed as medium.
The re-appointment of a key managerial personnel for a significant term, especially one with extensive experience and a proven track record with the company, is generally viewed positively by the market.
India Pesticides Limited announced the outcome of its Board Meeting held on February 9, 2026. The Board considered and approved the unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The company also approved the re-appointment of Mr. Dheeraj Kumar Jain as the Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) for a second term of five consecutive years. This new term will commence from January 23, 2026, and conclude on January 22, 2031.
Mr. Dheeraj Kumar Jain, a Master’s degree holder in Chemical Engineering, brings over 50 years of extensive industry experience. He has been associated with India Pesticides Limited for more than 30 years and has served as CEO since 2021, significantly contributing to research, manufacturing, and process optimization. He is not related to any directors, KMPs, or promoters of the company and is not debarred from holding such an office by any regulatory authority.
The Board Meeting commenced at 05:15 p.m. (IST) and concluded at 07:00 p.m. (IST). The unaudited financial results are also available on the company's website.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.